XW133D7 – Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
PCS Table
|
Section
X
New Technology
|
|||
|
Body System
W
Anatomical Regions
|
|||
|
Operation
1
Transfusion
|
|||
| Body Part | Approach | Device / Substance / Technology | Qualifier |
|
3
Peripheral Vein
|
3
Percutaneous
|
2
Plasma, Convalescent (Nonautologous)
|
5
New Technology Group 5
|
|
3
Peripheral Vein
|
3
Percutaneous
|
D
High-Dose Intravenous Immune Globulin
E
Hyperimmune Globulin
|
7
New Technology Group 7
|
|
4
Central Vein
|
3
Percutaneous
|
2
Plasma, Convalescent (Nonautologous)
|
5
New Technology Group 5
|
|
4
Central Vein
|
3
Percutaneous
|
D
High-Dose Intravenous Immune Globulin
E
Hyperimmune Globulin
|
7
New Technology Group 7
|